Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Keryx Biopharmaceuticals Inc.

Division of Akebia Therapeutics Inc.
www.keryx.com

Latest From Keryx Biopharmaceuticals Inc.

FDA Looks Ahead To Complex Product-Specific Guidances

The agency offers a glimpse of its regulatory agenda, although several have been carried over through multiple list updates.

Guidance Documents Generic Drugs

Exploring the US FDA's Upcoming Complex Generic Product-Specific Guidance Lists

The agency offers a glimpse of its regulatory agenda, although several have been carried over through multiple list updates.

Guidance Documents Generic Drugs

Ardelyx Plans Mid-2020 NDA Filing For Tenapanor In Hyperphosphatemia

The company reported positive Phase III data from a second trial testing the first-in-class therapy as monotherapy for managing hyperphosphatemia in patients on dialysis.

Financing Business Strategies

Deal Watch: Amazon Moves Into Rx Services With Acquisition Of PillPack

Celgene makes play into RNA-expression correction via neuroscience partnership and equity investment with Skyhawk. Novartis’ Sandoz agreed to commercialize Adamis’ Symjepi, a competitor to EpiPen, in the US.

Deals Commercial
See All

Company Information

  • Industry
  • Biotechnology
  • Pharmaceuticals
  • Therapeutic Areas
  • Renal System
  • Alias(es)
  • Ownership
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Akebia Therapeutics Inc.
  • Senior Management
  • Jodie Morrison, Interim CEO
    Scott A Holmes, CFO
    John F Neylan, MD, CMO
    Melissa Bradford-Klug, CBO
  • Contact Info
  • Keryx Biopharmaceuticals Inc.
    Phone: (617) 466-3500
    One Marina Park Dr.
    12th Fl.
    Boston, MA 02210
    USA
UsernamePublicRestriction

Register